EIF3A and hepatocellular carcinoma: Individual over-expression of 6 different EIF3 subunits occurs in various tumors: elevated 3H has been confirmed in 18% of breast and 30% of prostate cancers [7], 26% of hepatocellular carcinomas [8], and in non-small cell lung cancers [9], and colorectal cancers [10, 11].